Article
The influence of PD-L1 genetic variation on the prognosis of R0 resection colorectal cancer patients received capecitabine-based adjuvant chemotherapy: a long-term follow-up, real-world retrospective study.
Cancer chemotherapy and pharmacology - 1 May 2020
Su Jinsong, Dai Baiyun, Yuan Weitang, Wang Guixian, Zhang Zhiyong, Li Zhen, Liu Jinbo, Song Junmin
Abstract excerpt
PURPOSE: This study investigated the influence of PD-L1 genetic variation on the prognosis of R0 resection colorectal cancer (CRC) patients who received capecitabine-based adjuvant chemotherapy in real world. METHODS: A total of 315 CRC patients underwent R0 surgical resection and received capecitabine-based adjuvant chemotherapy were included. Clinical characteristics were collected from the hospital record...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.